©1996 by The American Society for Biochemistry and Molecular Biology, Inc.
Requirement for Phosphatidylinositol 3`-Kinase Activity in Platelet-derived Growth Factor-stimulated Tyrosine Phosphorylation of p125 Focal Adhesion Kinase and Paxillin (*)

(Received for publication, August 22, 1995; and in revised form, December 13, 1995)

Sara Rankin (1) Roya Hooshmand-Rad (2) Lena Claesson-Welsh (2) Enrique Rozengurt (1)(§)

From the  (1)Imperial Cancer Research Fund, P. O. Box 123, 44 Lincoln's Inn Fields, London WC2A 3PX, United Kingdom and the (2)Ludwig Institute for Cancer Research, Uppsala Branch, Box 595, S-751 24 Uppsala, Sweden

ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
FOOTNOTES
REFERENCES

ABSTRACT

The role of phosphatidylinositol 3`-kinase (PI 3`-kinase) activity in platelet-derived growth factor (PDGF)-stimulated tyrosine phosphorylation of focal adhesion kinase (p125) and paxillin has been examined. The tyrosine phosphorylation of p125 and paxillin in response to PDGF was markedly inhibited by wortmannin in a dose-dependent manner. PDGF-stimulated PI 3`-kinase activity, membrane ruffle formation, and tyrosine phosphorylation of p125 and paxillin were all inhibited by the same low concentrations of wortmannin (>90% inhibition at 40 nM). In contrast, tyrosine phosphorylation of p125 and paxillin in response to bombesin, endothelin, and phorbol 12,13-dibutyrate was not inhibited by wortmannin in these cells. Furthermore, LY294002, an inhibitor of PI 3`-kinase structurally unrelated to wortmannin, also inhibited PDGF-stimulated p125 tyrosine phosphorylation. PDGF was shown to stimulate the tyrosine phosphorylation of p125 in porcine aortic endothelial (PAE) cells transfected with the wild type PDGF-beta receptors, but not in PAE cells transfected with PDGF-beta receptors in which the PI 3`-kinase binding sites (Tyr-740/751) were replaced by phenylalanine. PDGF-stimulated, PI 3`-kinase-dependent tyrosine phosphorylation of p125 was not inhibited by rapamycin, and thus it was dissociated from the activation of p70 S6 kinase, previously identified as a molecular downstream target of PI 3`-kinase.

Thus, we have identified a PI 3`-kinase-dependent signal transduction pathway in the action of PDGF, which leads to the phosphorylation of p125 and paxillin.


INTRODUCTION

Platelet-derived growth factor (PDGF) (^1)is a 30-kDa polypeptide dimer that regulates cellular proliferation, chemotaxis, and cytoskeletal reorganization(1, 2, 3) . The binding of PDGF to individual receptor chains stimulates their dimerization and subsequent transphosphorylation(2, 4) . Cytoplasmic effector proteins such as phospholipase C(5, 6, 7, 8) , SH2-containing protein phosphotyrosine phosphatase(9) , GAP(10, 11) , the p85 subunit of PI 3`-kinase(12, 13) , GRB-2/sem-5(14) , and the Src family of protein tyrosine kinases (15) associate with specific phosphorylated tyrosine residues on the receptor chains via their SH2 domains(16, 17) . Once bound to the receptor, many of these proteins are phosphorylated on tyrosine by the intrinsic tyrosine kinase activity of the receptor. PDGF also stimulates the tyrosine phosphorylation of the focal adhesion-associated proteins, p125 and paxillin (18, 19) . p125 is a cytosolic tyrosine kinase that lacks SH2 and SH3 domains but associates with other proteins including v-Src and paxillin(20, 21, 22, 23, 24) . Paxillin contains multiple domains that can interact with vinculin, p125, and other cytoskeletal proteins(24, 25, 26) . The signal transduction pathways underlying PDGF-stimulated tyrosine phosphorylation of p125 and paxillin have not yet been elucidated.

PI 3`-kinase phosphorylates inositol phospholipids on the D3 position. In vivo this enzyme is thought to phosphorylate the head group of PtdIns(4, 5) P(2) to yield PtdIns (3, 4, 5) P(3), and this lipid has been postulated to act as a second messenger(27, 28, 29, 30, 31) . p70 has been identified as one of the putative molecular downstream targets of PI 3`-kinase activity (32, 33, 34, 35) (but see also (36) ). There is evidence, however, that PI 3`-kinase-regulated signaling bifurcates upstream of p70, implying that there must be other molecular downstream targets of PI 3`-kinase activity(32, 33) . PDGF stimulates the recruitment of polymerized actin into membrane ruffles and this cytoskeletal response is a PI 3`-kinase-dependent event (37, 38, 39) . Likewise, PDGF-stimulated chemotaxis is dependent on PI 3`-kinase activity(37) . It is not known, however, whether p70 or other molecular downstream targets of PI 3`-kinase are involved in these PDGF-stimulated processes.

PI 3`-kinase activity, membrane ruffle formation, and tyrosine phosphorylation of p125 and paxillin are stimulated by the same low concentrations of PDGF in Swiss 3T3 cells(18) . Furthermore, the tyrosine phosphorylation of p125 and paxillin by PDGF is critically dependent on the integrity of the actin cytoskeleton(18) . Cytochalasin D, an agent that prevents actin polymerization, inhibits PDGF-stimulated tyrosine phosphorylation of these cytoskeletal-associated proteins(18) . We reasoned, therefore, that PI 3`-kinase may lie upstream in a common signal transduction pathway stimulating the formation of membrane ruffles and the tyrosine phosphorylation of p125 and paxillin. To test this hypothesis, we utilized two different experimental approaches. First, PI 3`-kinase activity was directly inhibited by pretreatment of Swiss 3T3 cells with two structurally unrelated inhibitors, wortmannin and LY294002. Second, PAE cells were transfected with either wild type PDGF-beta receptors or PDGF beta receptors in which the PI 3`-kinase binding sites (Tyr-740/751) were replaced by phenylalanine. Using these two complementary approaches, we demonstrate here, for the first time, that the inhibition of PDGF-stimulated PI 3`-kinase activity, prevents the tyrosine phosphorylation of p125 and paxillin in response to PDGF in a selective manner.


EXPERIMENTAL PROCEDURES

Cell Culture

Cell cultures of Swiss 3T3 fibroblasts and PAE cells were maintained and propagated in DMEM and Ham's F-12 medium, respectively, as described previously(40, 41, 42) . PAE cells were serum-starved by incubation in Ham's F-12 medium containing 1 mg/ml bovine serum albumin for 12 h.

Construction of Stable PAE Cell Lines Expressing Wild Type and Y740F/Y751F PDGF beta Receptors

cDNA encoding the PDGF beta receptor (43) was subcloned into the pAlter vector(TM) (Promega Corp.) and site directed mutagenesis was performed to substitute phenylalanine residues for the tyrosine residues 740 and 751 using the Altered Sites in vitro mutagenesis system (Promega Corp.). Wild type and mutated cDNAs were inserted into the expression vector pcDNA1 neo (Invitrogen) and PAE cells transfected with the constructs by electroporation. Stable cell lines expressing wild type (48 times 10^3 receptors/cell) and Y740F/Y751F receptors (30 times 10^3 receptors/cell) were selected with neomycin (G-418 sulfate).

Immunoprecipitations

Quiescent cultures of Swiss 3T3 cells or serum-starved PAE cells were washed twice with DMEM and Ham's F-12 medium, respectively, treated with peptide factors in 1 ml of the corresponding medium as indicated and lysed at 4 °C in 1 ml of a solution containing 10 mM Tris/HCl, 5 mM EDTA, 50 mM NaCl, 30 mM sodium pyrophosphate, 50 mM NaF, 100 µM Na(3)VO(4), 1% Triton X-100, and 1 mM phenylmethylsulfonyl fluoride, pH 7.6 (lysis buffer). Lysates were clarified by centrifugation at 15,000 times g for 10 min and precleared by incubation with albumin-agarose for 1 h at 4 °C. After removal of albumin-agarose by brief (10 s) centrifugation, the supernatants were transferred to fresh tubes and proteins were immunoprecipitated for 12 h at 4 °C with agarose-coupled monoclonal antibodies either directed against phosphotyrosine or specific cellular proteins, as described previously(44, 45) . Immunoprecipitates were washed three times with lysis buffer, extracted in 2 times SDS-PAGE sample buffer (200 mM Tris-HCl, 6% SDS, 2 mM EDTA, 4% 2-mercaptoethanol, 10% glycerol, pH 6.8), and then fractionated by one-dimensional SDS-PAGE and analyzed as described under ``Results'' and in the figure legends.

p70 Mobility Shift Assay

Activation of p70 was determined by the appearance of slower migrating forms in SDS-PAGE as a result of phosphorylation on several clustered serine and threonine residues(46) . Immunoblot analysis on cell lysates was performed using a rabbit polyclonal antibody which recognized both alphaI and alphaII isoforms of p70/85(47) as described under ``Western Blotting.''

Western Blotting

After SDS-PAGE, proteins were transferred to Immobilon transfer membranes. Membranes were blocked using 5% nonfat dried milk in PBS, pH 7.2, and incubated for 2 h with either the anti-Tyr(P) mAbs (a mixture of Py20 and 4G10, 1 µg/ml antibody), GAP antiserum (1:1000), p70 rabbit polyclonal Ab (1 µg/ml), or anti-p125 Affiniti mAb (1:1000) as indicated, in PBS containing 0.05% Tween-20 and 3% nonfat dried milk. Immunoreactive bands were visualized using either I-labeled sheep anti-mouse IgG for anti-Tyr(P) and p125 or I-labeled protein A for the GAP antiserum and p70 antibody.

PI 3`-Kinase Assay

Phosphotyrosyl proteins were immunoprecipitated from cells as described above. The immunoprecipitates were assayed for phosphatidylinositol phosphorylation activity as described by Whitman et al.(48) .

Immunostaining of Cells

Quiescent Swiss 3T3 cells were washed in DMEM and then incubated for 10 min at 37 °C with endothelin (10 nM) and EGF (20 ng/ml). For staining of actin, cells were washed once with PBS, fixed in 3.7% paraformaldehyde in PBS for 30 min at 4 °C, and then permeabilized with PBS containing 0.2% Triton X-100 for 8 min at room temperature. The cells were then incubated with tetramethyl rhodamine B isothiocyanate-conjugated phalloidin (0.25 mg/ml) in PBS for 10 min at room temperature and visualized utilizing a light microscope.

Materials

Bombesin, wortmannin, albumin-agarose, agarose-linked anti-mouse IgG and phalloidin were obtained from Sigma. Ham's F-12 medium was from Life Technologies, Inc. Recombinant PDGF (BB homodimer), [-P]ATP (5000 Ci/mmol), I-labeled sheep anti-mouse IgG (15 µCi/µg), and I-labeled protein A (15 µCi/µg) were from Amersham. Py20 anti-Tyr(P) mAb and the mAb directed against paxillin (mAb 165) were from ICN, Buckinghamshire, United Kingdom (UK). The 4G10 anti-Tyr(P) mAb was from Tissue Culture Supplies, Buckinghamshire, UK. Anti-p125 mAb was obtained from Affiniti Research Products Ltd., Nottingham, UK. p70 rabbit polyclonal antibody was from Santa Cruz Biotechnology, Santa Cruz, CA. The anti-Tyr(P) mAb PY72 was obtained from the hybridoma development unit of the Imperial Cancer Research Fund. GAP antiserum was a gift of Dr. J. Downward, Imperial Cancer Research Fund. LY294002 was provided by Dr S. Cartlidge, Zeneca, UK.


RESULTS

The Effect of Wortmannin on PDGF- and Bombesin-stimulated Tyrosine Phosphorylation

Wortmannin directly binds to and inhibits the catalytic (110 kDa) subunit of PI 3`-kinase(49, 50, 51, 52) . To establish concentrations of wortmannin that effectively inhibited PI 3`-kinase activity in intact Swiss 3T3 cells stimulated with PDGF (3 ng/ml), we initially examined the effect of wortmannin on both PDGF-stimulated PI 3`-kinase activity and membrane ruffle formation. Fig. 1A shows that wortmannin caused a 90% inhibition of PDGF-stimulated PI 3`-kinase activity when cells were pretreated with 40 nM wortmannin for 10 min. The lowest concentration of wortmannin that produced an effective inhibition of PDGF-stimulated membrane ruffle formation was found to be 30 nM (data not shown).


Figure 1: Effect of wortmannin on PDGF-stimulated PI 3`-kinase activity and the tyrosine phosphorylation of proteins in response to PDGF and bombesin. A, quiescent Swiss 3T3 cells were preincubated for 10 min at 37 °C with 0, 20, or 40 nM wortmannin. Cells were subsequently incubated with 3 ng/ml PDGF for 10 min and then lysed. The lysates were immunoprecipitated with anti-Tyr(P) mAb, and the PI 3`-kinase activity in the immunoprecipitates was assayed. The autoradiogram obtained was scanned with an LKB Ultrascan XL densitometer to quantify phospholipids in terms of peak area. Values correspond to the phosphorylation of PI expressed as a percentage of the maximal response. The results shown are representative of at least three experiments. B, cells were preincubated in the presence (+) or absence(-) of 30 nM wortmannin for 10 min, subsequently incubated for 10 min with either 3 or 30 ng/ml PDGF or 10 nM bombesin and then lysed. The lysates were immunoprecipitated with the anti-Tyr(P) mAb PY72 and then analyzed by immunoblotting with either anti-Tyr(P) mAbs (PY) (a mixture of PY20 and 4G10) or a GAP antiserum (GAP) as indicated. In this and subsequent figures, representative autoradiograms are shown of experiments repeated at least three times.



To determine the effect of wortmannin on the tyrosine phosphorylation of proteins in response to PDGF and bombesin, quiescent Swiss 3T3 cells were preincubated with 30 nM wortmannin for 10 min and then incubated for another 10 min in the presence of either 3 or 30 ng/ml PDGF or 10 nM bombesin. The cell lysates were immunoprecipitated with the anti-Tyr(P) mAb PY72 and then analyzed by SDS-PAGE, followed by immunoblotting with a mixture of the anti-Tyr(P) mAb PY20 and 4G10. In agreement with our previous results(18) , PDGF stimulated the tyrosine phosphorylation of distinct substrates at different concentrations (Fig. 1B). Bands with M(r) 110,000-130,000 and 70,000-75,000 were phosphorylated on tyrosine in response 3 ng/ml PDGF, while their intensity was markedly reduced at 30 ng/ml PDGF, a concentration of PDGF that stimulated the phosphorylation of numerous other proteins (Fig. 1B). Preincubation of cells with 30 nM wortmannin caused a marked decrease in the tyrosine phosphorylation of the M(r) 110,000-130,000 and 70,000-75,000 bands stimulated by 3 ng/ml PDGF. Several lines of evidence indicate that this effect of wortmannin was selective. (a) At both 3 and 30 ng/ml PDGF, the most prominent band phosphorylated on tyrosine has a M(r) 170,000-190,000 and corresponds to the autophosphorylated alpha and beta PDGF receptor chains(2, 3) . Pretreatment of cells with wortmannin had no effect on the degree of tyrosine phosphorylation of the PDGF receptor chains stimulated by either 3 or 30 ng/ml PDGF, implying that wortmannin did not interfere with PDGF receptor autophosphorylation in Swiss 3T3 cells (Fig. 1B). (b) Wortmannin had no apparent effect on the tyrosine phosphorylation of multiple proteins stimulated by 30 ng/ml PDGF. (c) Accordingly, wortmannin pretreatment of cells had no effect on PDGF-stimulated tyrosine phosphorylation of GAP (Fig. 1B) or the mobilization of intracellular Ca that occurs as a result of PDGF activation of phospholipase C (results not shown). These results suggest that the inhibitory effect of wortmannin on PDGF-stimulated tyrosine phosphorylation is selective for a subset of proteins.

The neuropeptide, bombesin, stimulates the tyrosine phosphorylation of multiple proteins including the broad bands of M(r) 110,000-130,000 and 70,000-80,000(45) . In contrast to PDGF, the effects of neuropeptides are mediated through G-protein-coupled seven transmembrane receptors (53) that do not stimulate PI 3`-kinase activity in Swiss 3T3 cells(45, 54, 55) . Hence, bombesin-stimulated tyrosine phosphorylation of proteins should not be inhibited by wortmannin. As shown in Fig. 1B, preincubation of cells with 30 nM wortmannin had no effect on the bombesin-stimulated tyrosine phosphorylation of the broad bands of M(r) 110,000-130,000 and 70,000-80,000. Indeed wortmannin up to 100 nM had no effect on bombesin-stimulated tyrosine phosphorylation of proteins (results not shown). In addition, bombesin-stimulated formation of actin stress fibers is not affected by wortmannin pretreatment of cells (results not shown). Thus wortmannin distinguishes between PDGF and bombesin-stimulated tyrosine phosphorylation of specific proteins and cytoskeletal changes.

Effect of Wortmannin on PDGF-, Bombesin-, EGF-, Endothelin-, and PDB-stimulated Tyrosine Phosphorylation of p125

The cytosolic tyrosine kinase p125(20, 21) has recently been identified as a prominent component of the M(r) 110,000-130,000 band, which is tyrosine-phosphorylated in response to either PDGF at low concentrations or bombesin(18, 19, 44, 56) . The effect of wortmannin on the tyrosine phosphorylation of p125 in response to either PDGF or bombesin was therefore determined.

Cells were preincubated with wortmannin (0-40 nM) and then stimulated with either 3 ng/ml PDGF or 10 nM bombesin. The cell lysates were immunoprecipitated with an anti-Tyr(P) mAb and the immunoprecipitates analyzed by immunoblotting with an anti-p125 mAb. The results shown in Fig. 2(A and B) indicate that wortmannin induced a dramatic dose-dependent inhibition of the tyrosine phosphorylation of p125 in response to 3 ng/ml PDGF. In five independent experiments, pretreatment of cells with 30 nM wortmannin for 10 min produced an 85 ± 6% inhibition of the tyrosine phosphorylation of p125 in response to subsequent stimulation with PDGF (3 ng/ml). In contrast the tyrosine phosphorylation of p125 stimulated with 10 nM bombesin was not inhibited by preincubation of the cells with wortmannin up to 40 nM.


Figure 2: Effect of wortmannin on PDGF-, EGF-, bombesin-, endothelin- and PDB-stimulated tyrosine phosphorylation of p125. A, quiescent Swiss 3T3 cells were preincubated for 10 min at 37 °C with wortmannin (0-40 nM). Cells were subsequently incubated with either 10 nM bombesin or 3 ng/ml PDGF for 10 min, lysed, and then immunoprecipitated with the anti-Tyr(P) mAb PY72. Immunoprecipitates were analyzed by immunoblotting with anti-p125 mAb. B, the autoradiogram obtained in A was scanned with an LKB Ultrascan XL densitometer to quantify phosphoproteins in terms of peak area. Values correspond to the phosphorylation of p125 expressed as a percentage of the maximal response in response to 10 nM bombesin (open circles) or 3 ng/ml PDGF (closed circles). C, quiescent Swiss 3T3 cells were preincubated for 10 min at 37 °C with or without wortmannin (30 nM). Cells were subsequently incubated with either 3 ng/ml PDGF, 10 ng/ml EGF, 10 nM bombesin, 10 nM endothelin (End), or 100 nM PDB for 10 min and lysed. The cell lysates were then immunoprecipitated with the anti-Tyr(P) mAb PY72. Immunoprecipitates were analyzed by immunoblotting with anti-p125 mAb.



To extend the results presented above, we examined the wortmannin sensitivity of p125 tyrosine phosphorylation in response to EGF, endothelin, and PDB in Swiss 3T3 cells. Here we demonstrate, for the first time, that EGF stimulated an increase in the tyrosine phosphorylation of p125 (3.6 ± 1-fold, n = 4) in Swiss 3T3 cells. EGF-stimulated phosphorylation of p125 was inhibited by 85 ± 12% when the cells were pretreated with 30 nM wortmannin (Fig. 2C), consistent with an inhibition of EGF-stimulated PI 3`-kinase activity by wortmannin (data not shown). In accord with the data obtained with PDGF, EGF stimulated the rapid formation of membrane ruffles in Swiss 3T3 cells, a response that was markedly inhibited by pretreatment of the cells with 30 nM wortmannin for 10 min (data not shown).

Endothelin, a neuropeptide that acts through a different G-protein-coupled receptor to bombesin also stimulates tyrosine phosphorylation of p125 and formation of actin stress fibers in Swiss 3T3 cells(44, 57) . In contrast to the results obtained with PDGF and EGF, endothelin-stimulated p125 tyrosine phosphorylation and actin reorganization were not affected by pretreatment of the cells with 30 nM wortmannin for 10 min (Fig. 2C and results not shown). In addition, the tyrosine phosphorylation of p125 in response to direct activation of protein kinase C by PDB (56) was not affected by pretreatment of the cells with 30 nM wortmannin (Fig. 2C).

Effect of LY294002 on PDGF- and Bombesin-stimulated p125 Tyrosine Phosphorylation

In order to substantiate the results obtained with wortmannin, we examined if a structurally unrelated compound, LY294002 (a flavonoid related to quercetin), which has been identified as a specific inhibitor of PI 3`-kinase with an IC of 1-10 µM(58) , also inhibits PDGF-stimulated p125 tyrosine phosphorylation in a selective manner. Fig. 3shows that pretreatment with LY294002 inhibited p125 tyrosine phosphorylation induced by PDGF in a dose-dependent fashion. At 10 µM LY294002 inhibited PDGF-stimulated p125 tyrosine phosphorylation by 65%. In contrast, LY294002 had only a slight effect on p125 tyrosine phosphorylation in response to bombesin (Fig. 3). In addition, anti-Tyr(P) immunoblots of anti-Tyr(P) immunoprecipitates of lysates of cells stimulated with 3 ng/ml PDGF showed that 10 µM LY294002 inhibited the tyrosine phosphorylation of the M(r) 110,000-130,000 and 70,000-75,000 bands, but did not interfere with the autophosphorylation of the PDGF receptor or with the tyrosine phosphorylation of other substrates induced by 30 ng/ml PDGF (results not shown). In contrast, 10 µM LY294002 had no effect on the tyrosine phosphorylation of the M(r) 110,000-130,000 and 70,000-75,000 bands stimulated by bombesin (results not shown). Thus LY294002, like wortmannin, inhibits PDGF-stimulated tyrosine phosphorylation of a subset of proteins including p125 in a selective manner. The results presented in Fig. 1Fig. 2Fig. 3suggest that PDGF stimulates tyrosine phosphorylation of p125 through a PI 3`-kinase-dependent pathway.


Figure 3: Effect of LY294002 on the tyrosine phosphorylation of p125 in response to PDGF and bombesin. Quiescent Swiss 3T3 cells were washed and preincubated for 1 h at 37 °C in DMEM with or without LY294002 (1-15 µM). Cells were subsequently incubated with either 10 nM bombesin or 3 ng/ml PDGF for 10 min, lysed, and then immunoprecipitated with the anti-Tyr(P) mAb PY72. Immunoprecipitates were analyzed by immunoblotting with anti-p125 mAb.



PDGF Receptors Lacking the Major PI 3`-Kinase Binding Sites Do Not Stimulate Tyrosine Phosphorylation of p125

Next we used an alternative system to examine further the role of PI 3`-kinase in PDGF-stimulated tyrosine phosphorylation of p125. Wild type PDGF beta receptors and mutated receptors with the tyrosine residues at positions 740 and 751 replaced by phenylalanine residues (Y740F/Y751F) were expressed in PAE cells that had been transfected with the appropriate cDNAs. As previously reported, both PDGF-stimulated recruitment of PI 3`-kinase to the receptor and accumulation of PtdIns(3, 4, 5) -P(3) were markedly reduced in PAE cells transfected with mutated receptors(38) . Furthermore, PDGF does not stimulate either membrane ruffle formation or chemotaxis in PAE cells expressing Y740F/Y751F receptors(37, 38) . Here we examined whether PDGF stimulates p125 tyrosine phosphorylation in PAE cells transfected with wild type and Y740F/Y751 PDGF receptors.

The results presented in Fig. 4demonstrate that PDGF stimulates the tyrosine phosphorylation of p125 in PAE cells expressing wild type PDGF-beta receptors. In contrast, PDGF failed to stimulate an increase in the tyrosine phosphorylation of p125 in PAE cells expressing Y740F/Y751F PDGF-beta receptors (Fig. 4). This result suggests that PDGF-stimulated tyrosine phosphorylation of p125 is dependent on the interaction of the p85 regulatory subunit of PI 3`-kinase with the PDGF receptor chains. It is interesting to note that PAE cells expressing the Y740F/Y751F mutated PDGF-beta receptors exhibit a higher basal level of p125 tyrosine phosphorylation and that these cells have previously been demonstrated to contain higher levels of PI 3`-lipids (59) . This result provides an independent line of evidence supporting the conclusion that PDGF-stimulated tyrosine phosphorylation of p125 is dependent on the activation of PI 3`-kinase.


Figure 4: PDGF-stimulated tyrosine phosphorylation of p125 in PAE cell lines expressing wild type or mutant PDGFR-beta receptors. PAE cells expressing wild type PDGFR-beta or PDGFR-beta Y740F/Y751F mutant receptors molecules were incubated with PDGF (0-30 ng/ml) for 10 min at 37 °C. The cells were lysed, and the lysates were immunoprecipitated with the anti-Tyr(P) mAb PY72 and then analyzed by immunoblotting with anti-p125 mAb.



The Effect of Wortmannin on PDGF- and Bombesin-stimulated Tyrosine Phosphorylation of Paxillin

The focal adhesion-associated protein paxillin (25, 26) has recently been identified as a major component of the M(r) 70,000-80,000 band, tyrosine-phosphorylated in response to either PDGF at low concentrations or bombesin(18, 60) . As tyrosine phosphorylation of paxillin and p125 has been shown to be coordinately regulated(61) , we examined the effect of wortmannin on the tyrosine phosphorylation of paxillin in response to bombesin and PDGF. Quiescent Swiss 3T3 cells were preincubated with wortmannin (0-30 nM) and then stimulated with either PDGF (3 ng/ml) or 10 nM bombesin. In other experiments the cells were preincubated with 30 nM wortmannin and then treated with increasing concentrations of PDGF. The cell lysates were immunoprecipitated with the anti-paxillin mAb 165 and the immunoprecipitates analyzed by immunoblotting with anti-Tyr(P) mAbs. The results shown in Fig. 5clearly demonstrate that wortmannin inhibited the tyrosine phosphorylation of paxillin in response to various concentrations of PDGF. In contrast, wortmannin had no effect on bombesin-stimulated tyrosine phosphorylation of paxillin.


Figure 5: Effect of wortmannin on PDGF- and bombesin-stimulated tyrosine phosphorylation of paxillin. Upper, quiescent Swiss 3T3 cells were preincubated for 10 min at 37 °C with 0, 20 or 30 nM wortmannin and subsequently with 3 ng/ml PDGF or with 10 nM bombesin (Bom), as indicated. Lower, other cell cultures were preincubated for 10 min at 37 °C with (+) or without(-) 30 nM wortmannin, and subsequently incubated with PDGF (0-10 ng/ml) for 10 min. Cell lysates were immunoprecipitated with the anti-paxillin mAb 165 and then analyzed by immunoblotting with a mixture of anti-Tyr(P) mAbs.



Effect of Rapamycin on PDGF- and Bombesin-stimulated Tyrosine Phosphorylation of p125

p70 is a ubiquitous serine/threonine kinase that is activated by many mitogens through distinct signaling pathways(62) . p70 has been reported to be a molecular downstream target of PI 3`-kinase(32, 33, 34, 35) . In view of the results presented here, it was important to clarify whether p70 lies in the signaling pathway that mediates p125 tyrosine phosphorylation in response to PDGF. Bombesin, in contrast, activates p70, presumably by a protein kinase C-dependent signaling pathway (62) and bombesin-stimulated tyrosine phosphorylation of p125 has been shown to be protein kinase C-independent(56) .

The immunosuppressant rapamycin is a selective inhibitor of p70 activation in many cell types, including Swiss 3T3 cells(47) . We therefore examined the effect of rapamycin on the PDGF-stimulated tyrosine phosphorylation of p125. Quiescent cultures of Swiss 3T3 cells were pretreated with either rapamycin (20 nM for 20 min) or wortmannin (30 nM for 10 min) and then stimulated with PDGF (3 ng/ml) or bombesin (10 nM) for 10 min. Cell lysates were analyzed by immunoblotting with an anti-p70 polyclonal Ab and the phosphorylated form of p70 (pp70) was identified by its retarded mobility. The results shown in Fig. 6demonstrate that pretreatment of cells with rapamycin completely inhibited both the PDGF- and bombesin-stimulated phoshorylation of p70. Cell lysates derived from parallel cultures of Swiss 3T3 cells were immunoprecipitated with an anti-Tyr(P) mAb and the immunoprecipitates analyzed by immunoblotting with an anti-p125 mAb. As shown in Fig. 6, rapamycin had no effect on either PDGF- or bombesin-stimulated tyrosine phosphorylation of p125. Furthermore, pretreatment of Swiss 3T3 cells with rapamycin (20 nM) had no effect on PDGF-stimulated formation of membrane ruffles (data not shown). In contrast, wortmannin, which only slightly inhibited the PDGF-stimulated phoshorylation of p70 at 30 nM, dramatically inhibited the PDGF-stimulated tyrosine phosphorylation of p125 at this concentration (Fig. 6). Wortmannin had little effect on either the bombesin-stimulated phosphorylation of p70 or tyrosine phosphorylation of p125. These results therefore dissociate p70 activation from both PDGF- and bombesin-mediated p125 tyrosine phosphorylation.


Figure 6: Effect of rapamycin and wortmannin on PDGF- and bombesin-stimulated phosphorylation of p70 and the tyrosine phosphorylation of p125. Two parallel sets of cells were preincubated in the presence (+) or absence(-) of either 20 nM rapamycin (R) for 20 min or 30 nM wortmannin (W) for 10 min, the cells were subsequently incubated for 10 min with either 3 ng/ml PDGF or 10 nM bombesin and then lysed. The whole cell lysates from one set of cells were analyzed directly by immunoblotting with the anti-p70 rabbit polyclonal Ab. The lysates from the other set of cells were immunoprecipitated with anti-Tyr(P) mAb and then analyzed by immunoblotting with anti-p125 mAb.




DISCUSSION

The signal transduction pathways implicated in PDGF-induced tyrosine phosphorylation of the focal adhesion proteins p125 and paxillin had not been elucidated. The results presented here demonstrate that wortmannin at nanomolar concentrations dramatically inhibits PDGF-stimulated tyrosine phosphorylation of a subset of proteins, including p125 and paxillin in Swiss 3T3 cells. We verified that at these concentrations wortmannin inhibits PDGF-stimulated PI 3`-kinase activity and the reorganization of actin into membrane ruffles in Swiss 3T3 cells. In contrast, wortmannin at nanomolar concentrations does not affect p125 tyrosine phosphorylation induced by bombesin, which does not stimulate PI 3`-kinase in Swiss 3T3 cells(45, 54, 55) . Furthermore, the PI 3`-kinase inhibitor LY294002, which is structurally unrelated to wortmannin, also inhibited PDGF-stimulated p125 tyrosine phosphorylation in a selective manner. Utilizing PAE cells transfected with wild type and mutant PDGF beta receptors, we have shown that PDGF stimulates an increase in the tyrosine phosphorylation of p125 in PAE cells transfected with wild type PDGF beta receptors, but not in PAE cells that were transfected with PDGF beta receptors lacking the PI 3`-kinase binding sites. Therefore, employing different experimental approaches, we were able to demonstrate that the activation of PI 3`-kinase is necessary for PDGF-stimulated tyrosine phosphorylation of p125. These results suggest that PI 3`-kinase lies upstream in the signal transduction pathway linking the PDGF receptor to tyrosine phosphorylation of p125 and paxillin.

The results presented in this study should be distinguished from those recently published by Chen and Guan(19) . These authors reported that a small fraction (5-6%) of total cellular PI 3`-kinase activity can be recovered from p125 immunoprecipitates derived from lysates of NIH 3T3 cells treated with PDGF (19) . (^2)This association was maximal when the cells were stimulated with 25 ng/ml PDGF, a concentration of PDGF that did not stimulate the tyrosine phosphorylation of p125 in these cells. Furthermore, cytochalasin D, a potent inhibitor of PDGF-stimulated p125 tyrosine phosphorylation, did not affect the association(19) . Thus, the association between p125 and PI 3`-kinase seen in NIH 3T3 cells treated with high concentrations of PDGF^2 cannot account for the results presented in this study in which PI 3`-kinase was identified as an upstream element in a signal transduction pathway leading to p125 and paxillin tyrosine phosphorylation in cells treated with low concentrations of PDGF.

p70 has been identified as a molecular downstream target of PI 3`-kinase(32, 33, 34, 35) . It was important, therefore to determine whether p70 lies along a linear signaling pathway leading to p125 tyrosine phosphorylation in PDGF-treated cells. Here we have demonstrated that inhibition of the phosphorylation and activation p70, with the immunosuppressant rapamycin (47) , did not inhibit the PDGF-stimulated tyrosine phosphorylation of p125. In addition we found that rapamycin does not affect PDGF-stimulated membrane ruffling. We can therefore conclude that p70 activation and p125 tyrosine phosphorylation constitute two independent molecular downstream targets of PI 3`-kinase in PDGF-treated cells.

PDGF is a potent chemotactic agent for fibroblasts and other cell types (1, 37) . It has been shown that PI 3`-kinase activation is required for the formation of membrane ruffles and the stimulation of chemotaxis induced by growth factors(37, 38, 55) . Recently it has been shown that the small G protein Rac lies downstream of PI 3`-kinase, and there is evidence that PI 3`-lipids may promote Rac-GTP formation(59) . Furthermore, it has been demonstrated that there is a GTP-dependent and PDGF-stimulated association of Rac with PI 3`-kinase in Swiss 3T3 cells(63) . Activated Rac has been demonstrated to direct the formation of membrane ruffles and the assembly of focal adhesions(64) . In a previous study we demonstrated that the PDGF-stimulated tyrosine phosphorylation of p125 and paxillin is dependent on the integrity of the actin cytoskeleton(18) . The results presented here, demonstrating that PI 3`-kinase activation is required for PDGF-stimulated tyrosine phosphorylation of p125 and paxillin and the formation of membrane ruffles, establish another link between the reorganization of the actin cytoskeleton and the tyrosine phosphorylation of these focal adhesion-associated proteins. Taken together, all these findings suggest that there is a linear signal transduction pathway whereby ligation of the PDGF receptor activates PI 3`-kinase and thereby stimulates Rac-GTP formation. Activated Rac induces the formation of focal contacts, reorganization of the actin cytoskeleton, and the tyrosine phosphophorylation of p125 and paxillin. This signal transduction pathway could function in the regulation of chemotaxis. The recent demonstration that p125-deficient cells do not display polar migratory shape and exhibit a striking reduction in motility (65) is in agreement with this interpretation.

Activation of PI 3`-kinase in response to PDGF is thought to occur as a result of the association of the p85 regulatory subunit of PI 3`-kinase with the tyrosine-phosphorylated PDGF receptor chains(12, 13) . The recent demonstration that Ras may interact with and activate PI 3`-kinase suggests another mechanism for PI 3`-kinase activation in response to either PDGF or EGF in at least some cell types(66, 67) . The relative contribution of these two pathways leading to PI 3`-kinase activation and hence p125 tyrosine phosphorylation in response to PDGF or EGF warrants further experimental work.

The tyrosine phosphorylation of p125 and paxillin induced by bombesin and endothelin is dependent on the integrity of the actin cytoskeleton (56, 60) and the activity of the small GTP-binding protein Rho(57) . Here we demonstrate that the tyrosine phosphorylation of p125 in response to either bombesin or endothelin is not prevented by wortmannin at concentrations that virtually abolished the tyrosine phosphorylation of p125 and paxillin in response to PDGF and EGF. Similar results were obtained when LY294002 was used instead of wortmannin. An important implication of these results, therefore, is that there is a PI 3`-kinase-dependent and PI 3`-kinase-independent signal transduction pathway stimulating the tyrosine phosphorylation of p125 and paxillin in the same cells.


FOOTNOTES

*
The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore by hereby marked ``advertisement'' in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

§
To whom all correspondence should be addressed. Tel.: 44-171-269-3455; Fax: 44-171-269-3417.

(^1)
The abbreviations used are: PDGF, platelet-derived growth factor; anti-Tyr(P), anti-phosphotyrosine; DMEM, Dulbecco's modified Eagle's medium; EGF, epidermal growth factor; GAP, p21 GTPase-activating protein; IgG, immunoglobulin G; mAb, monoclonal antibody; PAE, porcine aortic endothelial cells; PBS, phosphate-buffered saline; PDB, phorbol 12,13-dibutyrate; PDGFR, platelet-derived growth factor receptor; PI 3`-kinase, phosphatidylinositol 3`-kinase; PtdIns, phosphatidylinositol; p125, p125 focal adhesion kinase; p70, p70 S6 kinase; PAGE, polyacrylamide gel electrophoresis; SH2, Src homology 2.

(^2)
Using the anti-p125 mAb, 2A7, we have not been able to immunoprecipitate PI3`kinase activity from Swiss 3T3 cells treated with PDGF (1-30 ng/ml). Furthermore, using agarose-bound GST-fusion proteins of the C- and N-terminal SH2 domains of the p85alpha subunit of PI 3`-kinase, we were unable to demonstrate any interaction with p125 in control or PDGF-stimulated cells. These observations may reflect a difference between Swiss 3T3 cells and NIH 3T3 cells.


REFERENCES

  1. Ross, R., Raines, E. W., and Bowen-Pope, D. F. (1986) Cell 46, 155-169 [Medline] [Order article via Infotrieve]
  2. Heldin, C.-H. (1992) EMBO J. 11, 4251-4259 [Medline] [Order article via Infotrieve]
  3. Claesson-Welsh, L. (1994) J. Biol. Chem. 269, 32023-32026 [Free Full Text]
  4. Kelly, J. D., Halderman, B. A., Grant, F. J., Murray, M. J., Seifert, R. A., Bowen-Pope, D. F., Cooper, J. A., and Kazlauskas, A. (1991) J. Biol. Chem. 266, 8987-8992 [Abstract/Free Full Text]
  5. Kumjian, D. A., Wahl, M. I., Rhee, S. G., and Daniel, T. O. (1989) Proc. Natl. Acad. Sci. U. S. A. 86, 8232-8236 [Abstract]
  6. Meisenhelder, J., Suh, P. G., Rhee, S. G., and Hunter, T. (1989) Cell 57, 1109-1122 [Medline] [Order article via Infotrieve]
  7. Wahl, M. I., Olashaw, N. E., Nishibe, S., Rhee, S. G., Pledger, W. J., and Carpenter, G. (1989) Mol. Cell. Biol. 9, 2934-2943 [Medline] [Order article via Infotrieve]
  8. Morrison, D. K., Kaplan, D. R., Rhee, S. G., and Williams, L. T. (1990) Mol. Cell. Biol. 10, 2359-2366 [Medline] [Order article via Infotrieve]
  9. Feng, G. S., Hui, C. C., and Pawson, T. (1993) Science 259, 1607-1611 [Medline] [Order article via Infotrieve]
  10. Kazlauskas, A., Ellis, C., Pawson, T., and Copper, J. A. (1990) Science 247, 1578-1581 [Medline] [Order article via Infotrieve]
  11. Kaplan, D. R., Morrison, D. K., Wong, G., McCormick, F., and Williams, L. T. (1990) Cell 61, 125-133 [Medline] [Order article via Infotrieve]
  12. Kaplan, D. R., Whitman, M., Schaffhausen, B., Pallas, D. C., White, M., Cantley, L., and Roberts, T. M. (1987) Cell 50, 1021-1029 [Medline] [Order article via Infotrieve]
  13. Kazlauskas, A., and Cooper, J. A. (1989) Cell 58, 1121-1133 [Medline] [Order article via Infotrieve]
  14. Lowenstein, E. J., Daly, R. J., Batzer, A. G., Li, W., Margolis, B., Lammers, R., Ullrich, A., Skolnik, E. Y., Bar-Sagi, D., and Schlessinger, J. (1992) Cell 70, 431-442 [Medline] [Order article via Infotrieve]
  15. Kypta, R. M., Goldberg, Y., Ulug, E. T., and Courtneidge, S. A. (1990) Cell 62, 481-492 [Medline] [Order article via Infotrieve]
  16. Anderson, D., Koch, C. A., Grey, L., Ellis, C., Moran, M. F., and Pawson, T. (1990) Science 250, 979-982 [Medline] [Order article via Infotrieve]
  17. Koch, C. A., Andersen, D., Moran, M. F., Ellis, C., and Pawson, T. (1991) Science 252, 668-674 [Medline] [Order article via Infotrieve]
  18. Rankin, S., and Rozengurt, E. (1994) J. Biol. Chem. 269, 704-710 [Abstract/Free Full Text]
  19. Chen, H.-C., and Guan, J.-L. (1994) J. Biol. Chem. 269, 31229-31233 [Abstract/Free Full Text]
  20. Hanks, S. K., Calalb, M. B., Harper, M. C., and Patel, S. K. (1992) Proc. Natl. Acad. Sci. U. S. A. 89, 8487-8491 [Abstract]
  21. Schaller, M. D., Borgman, C. A., Cobb, B. S., Vines, R. R., Reynolds, A. B., and Parsons, J. T. (1992) Proc. Natl. Acad. Sci. U. S. A. 89, 5192-5196 [Abstract]
  22. Cobb, B. S., Schaller, M. D., Leu, T.-H., and Parsons, J. T. (1994) Mol. Cell. Biol. 14, 147-155 [Abstract]
  23. Schlaepfer, D. D., Hanks, S., Hunter, T., and van der Geer, P. (1994) Nature 372, 786-791 [Medline] [Order article via Infotrieve]
  24. Hildebrand, J. D., Schaller, M. D., and Parsons, J. T. (1995) Mol. Biol. Cell 6, 637-647 [Abstract]
  25. Turner, C. E., and Miller, J. T. (1994) J. Cell Sci. 107, 1583-1591 [Abstract/Free Full Text]
  26. Turner, C. E., Glenney, J. R., Jr., and Burridge, K. (1990) J. Cell Biol. 111, 1059-1068 [Abstract]
  27. Downes, C. P., and Carter, A. N. (1991) Cell Signal 3, 501-503 [CrossRef][Medline] [Order article via Infotrieve]
  28. Stephens, L. R., Jackson, T. R., and Hawkins, P. T. (1993) Biochim. Biophys. Acta 1179, 27-75 [Medline] [Order article via Infotrieve]
  29. Auger, K. R., Serunian, L. A., Soltoff, S. P., Libby, P., and Cantley, L. (1989) Cell 57, 167-175 [Medline] [Order article via Infotrieve]
  30. Stephens, L. R., Hughes, K. T., and Irvine, R. F. (1991) Nature 351, 33-39 [CrossRef][Medline] [Order article via Infotrieve]
  31. Hawkins, P. T., Jackson, T. R., and Stephens, L. R. (1992) Nature 358, 157-159 [CrossRef][Medline] [Order article via Infotrieve]
  32. Chung, J., Grammer, T. C., Lemon, K. P., Kazlauskas, A., and Blenis, J. (1994) Nature 370, 71-74 [CrossRef][Medline] [Order article via Infotrieve]
  33. Weng, Q.-P., Andrabi, K., Klippel, A., Kozlowski, M. T., Williams, L. T., and Avruch, J. (1995) Proc. Natl. Acad. Sci. U. S. A. 92, 5744-5748 [Abstract]
  34. Weng, Q.-P., Andrabi, K., Kozlowski, M. T., Grove, J. R., and Avruch, J. (1995) Mol. Cell. Biol. 15, 2333-2340 [Abstract]
  35. Monfar, M., Lemon, K. P., Grammer, T. C., Cheatham, L., Chung, J., Vlahos, C. J., and Blenis, J. (1995) Mol. Cell. Biol. 15, 326-337 [Abstract]
  36. Ming, X.-F., Burgering, B. M. T., Wennström, S., Claesson-Welsh, L., Heldin, C.-H., Bos, J. L., Kozma, S. C., and Thomas, G. (1994) Nature 371, 426-429 [CrossRef][Medline] [Order article via Infotrieve]
  37. Wennström, S., Siegbahn, A., Yokote, K., Arvidisson, A.-K., Heldin, C.-H., Mori, S., and Claesson-Walsh, L. (1994) Oncogene 9, 651-660 [Medline] [Order article via Infotrieve]
  38. Wennström, S., Hawkins, P., Cooke, F., Hara, K., Yonezawa, K., Kasuga, M., Jackson, T., Claesson-Welsh, L., and Stephens, L. (1994) Curr. Biol. 4, 385-393 [Medline] [Order article via Infotrieve]
  39. Wymanin, M., and Arcaro, A. (1994) Biochem. J. 298, 517-520 [Medline] [Order article via Infotrieve]
  40. Todaro, G. J., and Green, H. (1963) J. Cell Biol. 17, 299-313 [Abstract/Free Full Text]
  41. Dicker, P., and Rozengurt, E. (1980) Nature 287, 607-612 [Medline] [Order article via Infotrieve]
  42. Mori, S., Ronnstrand, L., Yokote, K., Engstrom, A., Courtneidge, S. A., Claesson-Welsh, L., and Heldin, C.-H. (1993) EMBO J. 12, 2257-2264 [Abstract]
  43. Claesson-Welsh, L., Eriksson, A., Moren, A., Severinsson, L., Ek, B., Ostman, A., Betsholtz, C., and Heldin, C.-H. (1988) Mol. Cell. Biol. 8, 3476-3486 [Medline] [Order article via Infotrieve]
  44. Zachary, I., Sinnett-Smith, J., and Rozengurt, E. (1992) J. Biol. Chem. 267, 19031-19034 [Abstract/Free Full Text]
  45. Zachary, I., Gil, J., Lehmann, W., Sinnett-Smith, J., and Rozengurt, E. (1991) Proc. Natl. Acad. Sci. U. S. A. 88, 4577-4581 [Abstract]
  46. Ferrari, S., Bannwarth, W., Morley, S. J., Totty, N. F., and Thomas, G. (1990) Proc. Natl. Acad. Sci. U. S. A. 89, 7282-7285 [Abstract]
  47. Chung, J., Kuo, C. J., Crabtree, G. R., and Blenis, J. (1992) Cell 69, 1227-1236 [Medline] [Order article via Infotrieve]
  48. Whitman, M., Kaplan, D. R., Schaffhausen, B., Cantley, L., and Roberts, T. M. (1985) Nature 315, 239-242 [Medline] [Order article via Infotrieve]
  49. Yano, H., Nakanishi, S., Kimura, K., Hanai, N., Saitoh, Y., Fukui, Y., Nonomura, Y., and Matsuda, Y. (1993) J. Biol. Chem. 268, 25846-25856 [Abstract/Free Full Text]
  50. Okada, T., Sakuma, L., Fukui, Y., Hazeki, O., and Ui, M. (1994) J. Biol. Chem. 269, 3563-3567 [Abstract/Free Full Text]
  51. Powis, G., Bonjouklian, R., Berggren, M. M., Gallegos, A., Abraham, R., Ashendel, C., Zalkow, L., Matter, W. F., Dodge, J., Grindey, G., and Vlahos, C. J. (1994) Cancer Res. 54, 2419-2423 [Abstract]
  52. Kapeller, R., and Cantley, L. C. (1994) BioEssays 16, 565-576 [Medline] [Order article via Infotrieve]
  53. Rozengurt, E. (1992) Curr. Opin. Cell Biol. 4, 161-165 [Medline] [Order article via Infotrieve]
  54. Jackson, T. R., Stephens, L. R., and Hawkins, P. T. (1992) J. Biol. Chem. 267, 16627-16636 [Abstract/Free Full Text]
  55. Nobes, C. D., Hawkins, P., Stephens, L., and Hall, A. (1995) J. Cell Sci. 108, 225-233 [Abstract/Free Full Text]
  56. Sinnett-Smith, J., Zachary, I., Valverde, A. M., and Rozengurt, E. (1993) J. Biol. Chem. 268, 14261-14268 [Abstract/Free Full Text]
  57. Rankin, S., Morii, N., Narumiya, S., and Rozengurt, E. (1994) FEBS Lett. 354, 315-319 [CrossRef][Medline] [Order article via Infotrieve]
  58. Vlahos, C. J., Matter, W. F., Hui, K. Y., and Brown, R. F. (1994) J. Biol Chem. 269, 5241-5248 [Abstract/Free Full Text]
  59. Hawkins, P. T., Eguinoa, A., Qui, R.-G., Stokoe, D., Cooke, F. T., Walters, R., Wennström, S., Claesson-Welsh, L., Evans, T., Symons, M., and Stephens, L. (1995) Curr. Biol. 5, 393-403 [Medline] [Order article via Infotrieve]
  60. Zachary, I., Sinnett-Smith, J., Turner, C. E., and Rozengurt, E. (1993) J. Biol. Chem. 268, 22060-22065 [Abstract/Free Full Text]
  61. Rozengurt, E. (1995) Cancer Surveys 24, 81-96 [Medline] [Order article via Infotrieve]
  62. Ferrari, S., and Thomas, G. (1994) Crit. Rev. Biochem. Mol. Biol. 29, 385-413 [Abstract]
  63. Tolias, K. F., Cantley, L. C., and Carpenter, C. L. (1995) J. Biol. Chem. 270, 17656-17659 [Abstract/Free Full Text]
  64. Ridley, A. J., and Hall, A. (1992) Cell 70, 389-399 [Medline] [Order article via Infotrieve]
  65. Llic, D., Furuta, Y., Kanazawa, S., Takeda, N., Sobue, K., Nakatsuji, N., Nomura, S., Fujimoto, J., Okada, M., Yamamoto, T., and Aizawa, S. (1995) Nature 377, 539-544 [CrossRef][Medline] [Order article via Infotrieve]
  66. Sjolander, A., Yamamoto, K., Huber, B. E., and Lapetina, E. G. (1991) Proc. Natl. Acad. Sci. U. S. A. 88, 7908-7912 [Abstract]
  67. Rodriguez-Viciana, P., Warne, P. H., Dhand, R., Vanhaesebroeke, B., Gout, I., Fry, M. J., Waterfield, M. D., and Downward, J. (1994) Nature 370, 527-532 [CrossRef][Medline] [Order article via Infotrieve]

©1996 by The American Society for Biochemistry and Molecular Biology, Inc.